Indeed, superoxide dismutase 3 (SOD3) was shown to normalise the blood vessels in tumours and enhance transendothelial migration of effector T cells into tumours through promoting the stabilisation of HIF-2α [166]. This evidence concerns the gene EPAS1 and neoplasm.